Skip to main content

Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test center


The rapid spread of the coronavirus disease 2019 pandemic urged immense testing capacities as one cornerstone of infection control. Many institutions opened outpatient SARS-CoV-2 test centers to allow large number of tests in comparatively short time frames. With increasing positive test rates, concerns for a possible airborne or droplet contamination of specimens leading to false-positive results were raised. In our experimental series performed in a dedicated SARS-CoV-2 test center, 40 open collection tubes placed for defined time periods in proximity to individuals were found to be SARS-CoV-2 negative. These findings argue against false-positive SARS-CoV-2 results due to droplet or airborne contamination.


In December 2019, a novel Coronavirus, later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected as causative pathogen in a cluster of pneumonia of unknown cause  in Wuhan, China [1]. Since then, multiple assays for the detection of SARS-CoV-2 were established, enabling diagnosis of coronavirus disease 2019 (COVID-19). Besides nucleic acid amplification tests, antigen-based tests and serological assays are now available [2, 3]. An increasing demand for test capacities due to the pandemic spread prompted implementation of outpatient SARS-CoV-2 test centers. Considering the high sensitivity of SARS-CoV-2 polymerase chain reaction (PCR) used in highly frequented test center settings, concerns of false-positive PCR results due to contamination during pre-analytic processes occurred. The objective of the present study was to investigate, whether sampling tubes can be inadvertently contaminated with SARS-CoV-2 by droplets or aerosols generated by SARS-CoV-2 infected individuals during nasopharyngeal swab (NPS) sampling.

Material and methods


This study was performed at the SARS-CoV-2 test center of the University Hospital Zurich (USZ), Zurich, Switzerland. The center serves as referral center for all outpatient clinics of the USZ and is open for public. All individuals attending the SARS-CoV-2 test center are obliged to wear nose-mouth masks and to perform an alcohol-based hand disinfection at entry. Healthcare worker (HCW) register the personal data and assess symptoms compatible with COVID-19 using a standardized questionnaire before testing. A physical examination is not performed. During the swab procedure the nose-mouth mask is temporarily removed. After gathering the nasopharyngeal swab, individuals leave the test center directly and the results are provided by a phone call or short message service. In normal operation, the room is throughout ventilated by a tilted window. Between consecutive tests, the exterior doors are opened and all surfaces that were in contact with the tested individual are disinfected. Health care workers performing the swab procedure are wearing gloves, gowns, surgical masks (type 2R) and googles. Gloves are either changed or disinfected (for a maximum of five times) after every patient. Gowns are changed at the end of the shift, or if the assigned rooms for swab collection are left.

Experimental set-up

The experimental series was performed in two adjacent rooms designated for individuals with COVID-19 compatible symptoms or a history of relevant SARS-CoV-2 exposure (Fig. 1). Both rooms featured a similar room size (room A 18.96 m2 and room B 19.88 m2) and window area (room A and B around 1.7 m2). Both rooms have horizontal pivot windows. Individuals that presented for SARS-CoV-2 testing were seated in front of the window for NPS collection. In room A, the window was permanently tilted for continuous air exchange. In room B, the window was closed during the experimental runs, each lasting 60 min. Then, the window was tilted for about 10 min before launching the next experimental run. Both rooms featured no ventilation systems. In each room, three open tubes (15 ml, opening diameter 17 mm) filled with 3 ml viral transport medium (VTM) were placed at a distance of 50cm and 100cm to the patient. At each distance, one tube was sealed after 5, 10 and 60 min, respectively. This procedure was repeated for a total of three times. In addition, at both distances one separate open tube filled with 3 ml VTM was placed at the beginning of the first experimental series and was closed at the end of the third experimental series. To avoid contact transmission, HCW performed a hygienic hand disinfection routinely prior to handling of virus sample tubes. The overall number of persons that received SARS-CoV-2 testing in these rooms during the experimental series was registered. Results of the SARS-CoV-2 tests and the corresponding cycle thresholds (cT) values were retrieved from the electronic patient information system.

Fig. 1
figure 1

Experimental set-up. Room A: size of 18.96m2, window (at the back of the chair, on which individuals were seated; window area of around 1.7 m2) was permanently tilted throughout experimental series. Room B: size of 19.88m2, window was closed during an experimental series, after each experimental series the window (at the back of the chair, on which individuals were seated; window area of around 1.7 m2) was tilted for approximately 10 min prior to the next experimental series

SARS-CoV-2 polymerase chain reaction

All samples were analyzed at the Institute of Medical Virology of the University of Zurich. SARS-CoV-2 PCR analyses were performed with Roche Cobas SARS-CoV-2 IVD test (Roche Diagnostics, Mannheim, Germany) and an in-house high input PCR. Briefly, 100 µl of sample were lysed with 50 µl AVL buffer (Qiagen, Venlo, the Netherlands), precipitated with 150 µl EtOH and centrifuged at 21,000g for 1 min. The supernatant was removed, and the pellet resuspended with 35 µl of water. RT-qPCR was performed targeting the E- and the N-gene according to Corman et al. [4] with 16 µl eluate each using the TaqMan Fast Virus 1-Step Master Mix (Thermo Fisher, Waltham, MA, USA).


At the day of the experiments, totally 254 persons presented at the SARS-CoV-2 test center. Among these, 47 individuals tested positive, corresponding to a positivity rate of 18.5%. During the experimental series, 39 persons were tested for SARS-CoV-2 in room A and 41 persons in room B, respectively. In both rooms, the number of persons that received NPS sampling was similar for all predefined sampling periods (detailed information is provided in Table 1). Among the 80 individuals that were tested in either room A or room B, 19 (23.8%) tested positive. The median cT value of SARS-CoV-2 positive individuals was 22.38 (interquartile range (IQR) 19.24–25.73) for open reading frame 1 (ORF) and 22.68 (IQR 18.93–25.87) for envelope protein gene (E-gene), respectively. All 40 environmental samples tested negative for SARS-CoV-2 in both PCR methods applied.

Table 1 Number of persons that received SARS-CoV-2 testing during experimental series


The present study addressed the question whether false-positive results for SARS-CoV-2 could result from droplet or airborne contamination originating from individuals that have been sampled previously in the same room. Our experimental series encompassed various exposure times, two different settings regarding ventilation and two PCR assays, including a commonly used assay for SARS-CoV-2 diagnostics and a highly sensitive high input PCR, did not detect any contamination of open sampling tubes with SARS-CoV-2.

Prior studies reported contamination of several surfaces with SARS-CoV-2 next to infectious individuals [5]. Surroundings of infected individuals can either get contaminated by SARS-CoV-2 containing droplets, which is considered as by far the most relevant transmission mode, or exhaled aerosols or via contact transmission, e.g. if devices are touched after hands have been contaminated during coughing. The estimated median half-life of viable SARS-CoV-2 on different materials in an experimental setting was about 6.8 h and 5.6 h on plastics and stainless steel, respectively [6]. The high proportion of COVID-19 affected individuals in dedicated test centers promotes environmental contamination with SARS-CoV-2, and the level of contamination presumably increases with proximity to infected persons. As detailed above, the main transmission mode of SARS-CoV-2 occurs via droplets expelled during talking, coughing or sneezing [3]. For smaller droplets or aerosols, which can be generated during coughing by some individuals, ventilation becomes relevant for clearance [3, 7]. Our experimental set-up included a room without any enhanced air exchange and a room with continuous air exchange via tilted windows. Independent of the set-up all samples tested negative, even in a high input PCR with increased sensitivity.

Our study has some limitations. We can only provide information on the number of individuals that tested SARS-CoV-2 positive during the experimental series in both rooms. We did not register which patients were assigned to either room A or B. Nevertheless, as all samples tested negative, the assignment to the individual room does not seem crucial for the interpretation of the results. In addition, we did not swab surfaces to test for environmental contamination. However, considering the strict application of personal protective equipment, hand hygiene and surface disinfection, contamination around infected individuals is likely very limited. Strict application of hand hygiene and glove change of HCWs were likely crucial to prevent contamination of virus sample tubes.

In conclusion, we could not detect SARS-CoV-2 contamination of open collection tubes during NPS collection, even if these specimens remained unsealed for more than 3 h. Stringent use of personal protective equipment, including wearing of a surgical mask by the individual to be tested as a component of source control, hand hygiene and regular surface disinfection prevented successfully contamination. Furthermore, adequate specimen handling includes immediate closure after insertion of the NPS, thus minimizing the risk of contamination.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.



Coronavirus disease 2019


Cycle threshold


Envelope protein gene


Healthcare worker


Nasopharyngeal swab


Open reading frame 1


Polymerase chain reaction


Severe acute respiratory syndrome coronavirus 2


University Hospital Zurich


Viral transport medium


  1. World Health Organization. Rolling updates on coronavirus disease (COVID-19), Updated 31 July 2020.

  2. World Health Organization. Diagnostic testing for SARS-CoV-2. 2020.

  3. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.

    Article  CAS  Google Scholar 

  4. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.

    Article  Google Scholar 

  5. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323(16):1610–2.

    Article  CAS  Google Scholar 

  6. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–7.

    Article  Google Scholar 

  7. Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med. 2020;8(7):658–9.

    Article  CAS  Google Scholar 

Download references


We warmly thank Gülen Akdemir for realizing the experiments and Rebecca Morrone, Martin Ringer and all other health care workers from the test center for their commitment.


PWS is supported by the academic career program “Filling the Gap” of the Medical Faculty of the University of Zurich.

Author information

Authors and Affiliations



TS and PWS designed the experimental set up and drafted the initial manuscript. CS, MH and AT performed the virological analyses. HFG and BH helped in the experimental set up. All authors read, critically revised and approved the final manuscript.

Corresponding author

Correspondence to Thomas Scheier.

Ethics declarations

Ethics approval and consent to participate

As exclusively aggregated and anonymized SARS-CoV-2 results from individuals presenting at the test center were reported and solely environmental samples were gathered for analyses, a formal ethical evaluation was not needed.

Consent for publication

Not applicable.

Competing interests

PWS received travel grants from Pfizer and Gilead, speaker’s honorary from Pfizer outside of the submitted work. HS received speaker’s honorary and travel grant from AstraZeneca outside of the submitted work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scheier, T., Shah, C., Huber, M. et al. Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test center. Antimicrob Resist Infect Control 10, 51 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: